Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Biolitec reports strong growth in first half of 2012/13

Biolitec reports strong growth in first half of 2012/13

2nd April 2013

Biolitec has reported strong growth during the first half of its 2012/13 business year, achieving a group revenue total of 21.1 million euros (17.82 million pounds).

This equated to a year-on-year improvement of 9.1 percent, thanks to growing demand for the healthcare company's key products, including its ELVeS-Radial endoluminal laser treatment for veins.

During the period, the firm received a positive reception from doctors and patients for its new  laser system HOLA for the treatment of myoma and Laser HaemorrhoidoPlasty offering, while profit levels also increased.

Biolitec expressed particular satisfaction with the growing contribution of its emerging market operations to its overall performance, with its Arabian and Asian subsidiaries showing a 45 percent improvement on last year.

This is a key area of focus for the company as it seeks to "lay the basis of further growth adapted to the world market situation".

Biolitec remains one of the world's leading companies in the field of laser medicine and continues to carry out research into innovative treatment procedures and photodynamic therapies.ADNFCR-8000103-ID-801564976-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.